Cassidy A, Mossman S, Olivieri A, De Ridder M, Leroux-Roels G. Hepatitis b vaccine effectiveness in the face of global hbv genotype diversity. Expert review of vaccines. 2011;10(12):1709-15.Cassidy A,Mossman S,Olivieri A, et al.Hepatitis B vaccine effectiveness in the face of global ...
hepatitis B, the current status of hepatitis B vaccination is reviewed. The hepatitis B vaccine In 1982, two hepatitis B vaccines from France and the United States were licensed. They were subunit vaccines containing 22-nm HBsAg particles made from plasma of chronic HBsAg carriers. The preparation...
To evaluate the effectiveness of the hepatitis B virus (HBV) vaccination program in Greenland, which targets children born to mothers who are positive for HBV surface antigen (HBsAg), we determined vaccination coverage, levels of postvaccination antibodies, and frequency of breakthrough infections in...
aged 13 to 17 years who had received three or more doses of the Hepatitis B vaccine Reasons for hesitancy Percentage of U.S. families that refused vaccines due to a fear of vaccinations causing autism Percentage of U.S. adults that refused the flu vaccine because they did not trust ...
A decision-analysis model was used to assess the cost effectivenessof three strategies for preventing hepatitis B infection: (1) vaccinatingeveryone, (2) screening everyone and vaccinating those without evidence ofimmunity, and (3) neither screening nor vaccinating, but responding to knownexposure with...
To determine the cost-effectiveness of substituting hepatitis A–B vaccine for hepatitis B vaccine when healthcare and public safety workers in the western United States are immunized to protect against occupational exposures to hepatitis B. A cohort of 100,000 hypothetical healthcare and public safet...
Current therapeutic approaches to control chronic hepatitis B (CH-B), such as administrations of interferon or nucleoside analogs, are still unsatisfactory. Vaccination with conventional hepatitis B (HB) vaccine is another therapeutic approach with lower cost and potentially long-lasting beneficial effect...
A study has been set up to evaluate the efficacy of hepatitis B vaccine alone, without the use of immunoglobulin in interrupting perinatal transmission of hepatitis B virus from carrier mothers to their babies. A 4 dose schedule was used. 14 of 17 babies of e antigen positive carrier mothers...
Administration of hepatitis B vaccine in winter as a significant predictor of the poor effectiveness of vaccination in rural Mongolia: evidence from a nati... Davaalkham,Ojima,Wiersma,... - 《Journal of Epidemiology & Community Health》 - 2007 - 被引量: 37 Protective Efficacy of a Recombinant...
OBJECTIVE: To analyze the cost-effectiveness of the national Perinatal Hepatitis B Prevention Program (PHBPP) over the lifetime of the 2009 US birth cohort and compare the costs and outcomes of the program to a scenario without PHBPP support. PHBPP's goals are to ensure all infants born to...